- US11926655utility2024Active Mmp9-binding Peptide0 cites
- US11884678utility2024Method for Producing a Spirooxindole Derivative0 cites
- US11866472utility2024Peptide for Treating Retinitis Pigmentosa0 cites
- US11845786utility2023Peptides Inhibiting KLK1, KLK4, or KLK4 and KLK80 cites
- US11834427utility2023Griseofulvin Compound0 cites
- US11806339utility2023Combination Therapy of Axl Inhibitor and EGFR Tyrosine Kinase Inhibitor0 cites
- US11795236utility2023Method for Treating Cancer Comprising Administration of Anti-her2 Antibody-drug Conjugate0 cites
- US11667642utility2023Method for Producing 3,6-disubstituted-imidazo[1,2-b]pyridazine Derivative0 cites
- US11661451utility2023Anti-cd147 Antibody0 cites
- US11643658utility2023Oligonucleotides, Manufacturing Method for Same, and Target RNA Site-specific Editing Method0 cites
- US11633493utility2023Antibody-drug Conjugate0 cites
- US11628223utility2023Antibody-drug Conjugates Comprising Substituted Benzo[e]pyrrolo[1,2-α][1,4]diazepines0 cites
- US11618785utility2023Anti-cd3 Antibody and Molecules Comprising the Antibody0 cites
- US11583590utility2023Antibody-pyrrolobenzodiazepine Derivative Conjugate and Method of Use Thereof for Treating a Tumor0 cites
- US11584800utility2023Method of Treating Cancer Comprising Administration of Anti-her2 Antibody-drug Conjugate0 cites
- US11555204utility2023Promoter of Hspa5 Gene0 cites
- US8344029utility2013Substituted Propanamide Derivative and Pharmaceutical Composition Containing the Same0 cites
← PreviousPage 3 of 3